# Cord Blood Expansion on Mesenchymal Stem Cells

> **NCT00498316** · PHASE1 · COMPLETED · sponsor: **M.D. Anderson Cancer Center** · enrollment: 98 (actual)

## Conditions studied

- Myelodysplastic Syndrome
- Leukemia

## Interventions

- **PROCEDURE:** Cord Blood Infusion
- **DRUG:** Busulfan
- **DRUG:** Fludarabine
- **DRUG:** Rituximab
- **OTHER:** ATG
- **DRUG:** Cyclophosphamide
- **DRUG:** Clofarabine
- **RADIATION:** Total Body Irradiation (TBI)
- **DRUG:** Melphalan
- **DRUG:** Tacrolimus
- **DRUG:** Mycophenolate Mofetil
- **DRUG:** G-CSF

## Key facts

- **NCT ID:** NCT00498316
- **Lead sponsor:** M.D. Anderson Cancer Center
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-07-03
- **Primary completion:** 2016-10
- **Final completion:** 2016-10
- **Target enrollment:** 98 (ACTUAL)
- **Last updated:** 2020-02-28

## Collaborators

- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00498316

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00498316, "Cord Blood Expansion on Mesenchymal Stem Cells". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT00498316. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*